To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
A 32-year-old right-handed woman developed persistent fever with malaise and nausea. The symptoms persisted for 2 weeks, after which she was admitted because of delirium, amnesia, and repetitive generalized convulsions with loss of consciousness. She had no remarkable past and family medical history, which included a history of abortions and thyroiditis. However, she had gained a body weight of 20 kg in the 1 year preceding this episode. She was not on medication and did not smoke or consume alcohol.
This chapter speaks about an 82-year-old woman who was admitted with apparently sudden-onset neurological symptoms. On examination, this patient appeared well and comfortable. The patient's clinical evolution was characterized by a relentlessly progressive course over several weeks. The visual field defect expanded into a right homonymous hemianopia, and optic ataxia also developed on the left. Dysarthria and dysphagia worsened until she was dependent on tube feeding. The human prion diseases are a comparatively rare cause of dementia, with an estimated incidence of 1 case per million people per year, although some uncorroborated reports would place the true incidence much higher. Therapeutic options for all the human prion diseases are currently limited to palliation, as there are no agents capable of reliably causing a sustained improvement in clinical course. A large and diverse selection of drugs have been tried with limited success, including antivirals, antifungals, antibiotics, antimalarials, antidepressants, antioxidants, and analgesics.